Celgene (NASDAQ:CELG)

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, August 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Merrill Lynch recently released its September RIC Report, noting key strategy views and showing many sector views. One such view from the firm was that health care stocks are currently ...
Read Full Story »

Celgene Faces Multiple Clinical Holds From FDA

Celgene Corp. (NASDAQ: CELG) received an update from the U.S. Food and Drug Administration (FDA) early on Thursday. Although shares did not dip initially, this action could prove to be ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, August 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotechs Send Short Sellers Running for Cover

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Airlines, Celgene, Citigroup, Facebook, Hertz, Hilton, Ulta Beauty and Many More

Stocks were indicated to open higher yet again on Monday, with the Dow and S&P 500 challenging all-time highs. The bull market is now well over eight years old, but ...
Read Full Story »

Short Sellers Run for Cover From Major Biotech Stocks

The short interest data are out for the most recent settlement date, July 14. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, June 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Meet Jefferies Top 12 Picks in the Roaring Biotech Industry

The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Apple, Citigroup, Exxon, M&T Bank, Snap, Toyota, Twitter and Many More

Stocks were marginally lower on Tuesday morning, but the major indexes all remain within striking distance of their all-time highs. Now that the bull market is over eight years old, ...
Read Full Story »

How Transformative Is This Licensing Deal for BeiGene?

BeiGene Ltd. (NASDAQ: BGNE) saw its shares pop early on Thursday after the firm announced that it had entered into a strategic collaboration with Celgene Corp. (NASDAQ: CELG). The goal ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Bluebird, Celgene, Coach, 58.com, Gold Fields, Nike, Rite Aid, Vipshop, Waste Management and More

Stocks were indicated to open marginally higher on Friday after a two swing days this week. Thursday saw a large and broad sell-off, after a solid rally on Wednesday. Even ...
Read Full Story »

Analyst Predicts Major Short Squeeze in 4 Biotech Stocks to Buy

If any industry has done a head-spinning turnaround recently it was biotechnology. Last week saw the Nasdaq Biotech Index spike up almost 9%. While some was given back so far ...
Read Full Story »

Major Biotech Short Interest Surges

The short interest data are out for the most recent settlement date, June 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Agio Pharma Sinks on Midstage Trial

Agio Pharmaceuticals Inc. (NASDAQ: AGIO) saw its shares sink on Monday after the firm announced results from its midstage trial for the treatment of relapsed or refractory acute myeloid leukemia ...
Read Full Story »